Novacyt revenues half year 2017 ENGLISH Paris, France and Cambridge, UK – 20th July 2017 – Novacyt (ALTERNEXT: ALNOV), an international specialist in clinical diagnostics, today announces its unaudited revenues for...
Novacyt Financing PR ENG (20-06-17) FINAL Momentum towards profitability continues through H1 2017 Investing to support increased sales demand across business...
Novacyt FY16 financial results PR ENG Paris, France and Cambridge, UK – 27 April 2017 – Novacyt (ALTERNEXT: ALNOV), an international specialist in cancer and infectious disease diagnostics, today announces its...
Novacyt - Announces Bond Issue ENG Paris, France and Cambridge, UK – 6th April 2017 – Novacyt (ALTERNEXT: ALNOV), an international specialist in clinical diagnostics, today announces the Company has issued...
IRVINE, CA, and HERSTAL, BELGIUM – March 21, 2017 – MDxHealth SA (Euronext: MDXH.BR), today announced that it has signed a distribution agreement to make its SelectMDx™ for Prostate Cancer...
Novacyt - NOVAprep® Regulatory Update in US and China ENGLISH Paris, France and Cambridge, UK – 23rd February 2017 – Novacyt (ALTERNEXT: ALNOV), an international specialist in clinical diagnostics, today announces...
Delivers consolidated sales growth of 25% NOVAprep® sales increase 24% Group reiterates positive outlook Novacyt revenues full year 2016 ENGLISH...
novacyt-financing-english Paris, France and Cambridge, UK – 15 December 2016 – Novacyt (ALTERNEXT: ALNOV), an international specialist in clinical diagnostics, today announces a private equity placement raising gross €2.7m in an...
novacyt-technology-fast-50-award-english Paris, France and Cambridge, UK – 8 November 2016 – Novacyt (ALTERNEXT: ALNOV), an international specialist in clinical diagnostics, today announces it has won the Ile-de-France award of the Deloitte...
[vc_row][vc_column][vc_column_text]novacyt-half-year-2016-results-pr-english Paris, France and Cambridge, UK – 27th October 2016 – Novacyt (ALTERNEXT: ALNOV), an international specialist in clinical diagnostics, today announces audited financial results for the six months ended 30th...
| Cookie | Duration | Description |
|---|---|---|
| cookielawinfo-checkbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
| cookielawinfo-checkbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
| cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
| cookielawinfo-checkbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
| cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
| viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |
